Wall Street Just Erased $57 Billion From Micron. The Shortage Behind Its Boom Is Getting Worse.
Micron just posted the highest revenue guidance in its history while the shortage fueling its growth gets worse, yet Wall Street wiped out tens of billions in market cap anyway. The signal hiding inside that contradiction is worth understanding before…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
You don’t often see a trillion-dollar chipmaker shed tens of billions of dollars in market capitalization on a day when the shortage driving its earnings worsens. That is what happened to Micron Technology (NASDAQ:MU | MU Price Prediction) on Thursday.
The stock closed at $977.41, down 4.9% in the session. On the same day, Chinese AI chipmakers are raising prices on forthcoming Huawei and Cambricon accelerators because high-bandwidth memory has become prohibitively scarce and expensive in the grey channel there.
Those Chinese price signals do not translate cleanly into Micron revenue, because export restrictions distort that channel. They speak to global memory tightness rather than to sales into China. Micron is one of three companies that dominate advanced high-bandwidth memory production, alongside SK Hynix and Samsung, so scarcity in that market accrues mechanically to those three balance sheets.
Fifty-Seven Billion Gone in a Session
Micron’s fiscal Q3 2026 revenue came in at $41.46 billion, beating the $35.25 billion consensus by 17.60% and rising 345.7% year over year. Non-GAAP EPS of $25.11 beat the $20.28 consensus by 23.79%, the seventh consecutive EPS beat.
GAAP gross margin ran at 84.6%, with non-GAAP at 84.9%. Operating income of $33.32 billion rose 1,436% year over year. Free cash flow was $18.30 billion on capex of $7.83 billion.
Guidance for fiscal Q4 calls for revenue of $50 billion plus or minus $1 billion, non-GAAP EPS of $31 plus or minus $1, and gross margin of approximately 86%. It is the highest revenue outlook the company has ever issued.
CEO Sanjay Mehrotra said DRAM and NAND demand keeps outrunning supply and management does not yet have “line of sight as to when memory supply will be able to catch up with increasing demand”. That is the operating context the market discounted this week.
What The Contract Book Says
Micron has signed 16 Strategic Customer Agreements, typically five-year take-or-pay contracts, covering roughly 20% of DRAM volume and a third of NAND volume over the agreement period. Fourteen of the sixteen carry a minimum-price commitment worth about $100 billion cumulatively.
Micron is collecting roughly $18 billion in cash deposits and $4 billion in letters of credit against those obligations. Management described the deposits as separate binding commitments held during performance of the agreements.
HBM4 12-high volume ramp is tracking twice as fast as HBM3E 12-high, with over $1 billion in HBM4 revenue already shipped. Management expects tight supply-demand conditions to “persist beyond calendar 2027”, with only gradual improvement in 2028.
That is a pricing regime. The contract book converts it into visible revenue.
Market Reaction
Over the past week, the stock is up 2.01%, over the past month up 12.54%, and year to date up 242.67%. One-year performance is 599.28%.
The post-earnings reversal after fiscal Q3 was severe. The day-of move was +15.74%, but the one-week change was -19.61% and the thirty-day change was -32.39%. Over the same thirty days, SPY returned 0.89%, and Invesco QQQ Trust (NYSEARCA:QQQ) returned -5.71%.
All 8 recorded earnings periods in the reaction history were beats, with an average one-week change of -3.44%. The Q3 26 one-week and thirty-day drawdowns are the largest in that record.
An Intel (NASDAQ:INTC)-backed start-up entering the memory-chip market also added a competitive overhang to the session.
Bull Case
Hear the bear case first, because it has teeth. Memory has always been cyclical; the supply that cures a shortage is usually already being built, and the ten-year Treasury sits at 4.83%, the high of the supplied one-year series.
WTI crude is at $100 a barrel as of this writing, keeping the rate-shock scenario alive for growth semis. A stock up 242.67% year to date has priced in a great deal of good news.
The bull case still wins on the evidence. Q4 guidance of $50 billion in revenue at an 86% gross margin describes a business selling into a worsening shortage while locking customers into multi-year minimums. Forward PE sits at 6x against a trailing PE of 23x, with an analyst target price of $1,513.11 and 9 strong buys plus 35 buys versus 4 holds and 0 sells.
Bottom Line
The Chinese HBM price signal, the Q4 guide and the contract book all point in the same direction, even as the stock moves the other way. If you own Micron for the AI memory cycle, this session is noise against a lengthening shortage (the power, cooling, and networking suppliers riding the same buildout are the subject of a free report we put together here).
The forward catalyst worth watching is capital returns. Management said it intends to increase them from December 9, 2026, the second anniversary of the definitive CHIPS agreements, and said that “over time, we expect to return 100% of our excess cash to shareholders”.
A trillion-dollar memory maker selling into a shortage it cannot fully supply is a rare setup. The market gave a cheaper entry into an intact thesis.
Is MU Stock a Buy?
Micron looks attractive for long-term holders who can tolerate the volatility. The valuation looks demanding on trailing metrics and cheap on forward earnings; the shortage is intensifying, and the Strategic Customer Agreements give the next several years unusual revenue visibility for a memory maker.
SK Hynix (NASDAQ:SKHY) and Samsung compete for the same HBM demand, but the three-supplier structure benefits Micron directly, and it remains the only U.S.-based memory manufacturer. The real risk is macro. If the ten-year keeps climbing from 4.83% and WTI stays above $90, multiples in growth semis will compress regardless of fundamentals.
On balance, the fundamentals outweigh the macro overhang, and the stock has already done part of the work of resetting the entry. Verdict: Buy.
Contact [email protected] for any questions or corrections.
Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.
